INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candida | INO Message Board Posts


INO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  2131 of 2142  at  8/27/2021 2:46:46 PM  by

co3aii

The following message was updated on 8/28/2021 9:54:44 AM.

 In response to msg 2130 by  billmax
view thread

Re: INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800

 
Other than grants, no revenues except what they got from DoD, now cancelled.
 
Kim's choice for the Phase III, Brazil etc., is a smart move as infrastructure outside of the big cities  in those countries precludes the refrigeration needed by the other vaccines. Now lets see if INO can execute their plan and get approval in China too. 
 
To be more exact why are you invested in INO if not for future revenues? I was originally here for HPV and Glio, so for me the Covid vaccine is serendipitous. 
 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
2132 Re: INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800 billmax 0 8/27/2021 3:52:36 PM


Financial Market Data provided by
.
Loading...